The global market for Metabolism Drugs was estimated to be worth US$ 16200 million in 2023 and is forecast to a readjusted size of US$ 23350 million by 2030 with a CAGR of 5.3% during the forecast period 2024-2030

Metabolism Drugs - Market

Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.

USA is the largest supplier of Metabolism Drugs, with production revenue market share over 43%, while the sales market share is 40%. Europe, following USA, takes production revenue market share of 35% and the sales market share over 23%. That is to say, there are a large number of exports in Europe. Japan is an important market of Drugs for Metabolism Drugs in Asia, accounting for 9% production revenue market share and 10% sales revenue market share of global market.

Players with high-quality products are Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca and Beohrigher Ingelheim, with about 70% market shares.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Metabolism Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Metabolism Drugs by region & country, by Type, and by Application.

The Metabolism Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolism Drugs.

Market Segmentation

Scope of Metabolism Drugs - Market Report

Report Metric	Details
Report Name	Metabolism Drugs - Market
Forecasted market size in 2030	US$ 23350 million
CAGR	5.3%
Forecasted years	2024 - 2030
Segment by Type:	Glycogen Metabolism Disease Drug Lipid Metabolism Disease Drug Amino Acid Metabolism Drug Other
Segment by Application	Hospital Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Life Science, Metsubishi Tanabe Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metabolism Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Metabolism Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Metabolism Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Metabolism Drugs - Market size in 2030?

Ans: The Metabolism Drugs - Market size in 2030 will be US$ 23350 million.

What is the Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim share in Metabolism Drugs - Market?

Ans: Players with high-quality products are Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca and Beohrigher Ingelheim, with about 70% market shares.

Who are the main players in the Metabolism Drugs - Market report?

Ans: The main players in the Metabolism Drugs - Market are Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Life Science, Metsubishi Tanabe Pharma

What are the Application segmentation covered in the Metabolism Drugs - Market report?

Ans: The Applications covered in the Metabolism Drugs - Market report are Hospital, Retail Pharmacy

What are the Type segmentation covered in the Metabolism Drugs - Market report?

Ans: The Types covered in the Metabolism Drugs - Market report are Glycogen Metabolism Disease Drug, Lipid Metabolism Disease Drug, Amino Acid Metabolism Drug, Other

1 Market Overview

1.1 Metabolism Drugs Product Introduction

1.2 Global Metabolism Drugs Market Size Forecast

1.2.1 Global Metabolism Drugs Sales Value (2019-2030)

1.2.2 Global Metabolism Drugs Sales Volume (2019-2030)

1.2.3 Global Metabolism Drugs Sales Price (2019-2030)

1.3 Metabolism Drugs Market Trends & Drivers

1.3.1 Metabolism Drugs Industry Trends

1.3.2 Metabolism Drugs Market Drivers & Opportunity

1.3.3 Metabolism Drugs Market Challenges

1.3.4 Metabolism Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Metabolism Drugs Players Revenue Ranking (2023)

2.2 Global Metabolism Drugs Revenue by Company (2019-2024)

2.3 Global Metabolism Drugs Players Sales Volume Ranking (2023)

2.4 Global Metabolism Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Metabolism Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Metabolism Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Metabolism Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Metabolism Drugs

2.9 Metabolism Drugs Market Competitive Analysis

2.9.1 Metabolism Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Metabolism Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolism Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Glycogen Metabolism Disease Drug

3.1.2 Lipid Metabolism Disease Drug

3.1.3 Amino Acid Metabolism Drug

3.1.4 Other

3.2 Global Metabolism Drugs Sales Value by Type

3.2.1 Global Metabolism Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Metabolism Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Metabolism Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Metabolism Drugs Sales Volume by Type

3.3.1 Global Metabolism Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Metabolism Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Metabolism Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Metabolism Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Retail Pharmacy

4.2 Global Metabolism Drugs Sales Value by Application

4.2.1 Global Metabolism Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Metabolism Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Metabolism Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Metabolism Drugs Sales Volume by Application

4.3.1 Global Metabolism Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Metabolism Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Metabolism Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Metabolism Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Metabolism Drugs Sales Value by Region

5.1.1 Global Metabolism Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Metabolism Drugs Sales Value by Region (2019-2024)

5.1.3 Global Metabolism Drugs Sales Value by Region (2025-2030)

5.1.4 Global Metabolism Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Metabolism Drugs Sales Volume by Region

5.2.1 Global Metabolism Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Metabolism Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Metabolism Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Metabolism Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Metabolism Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Metabolism Drugs Sales Value, 2019-2030

5.4.2 North America Metabolism Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Metabolism Drugs Sales Value, 2019-2030

5.5.2 Europe Metabolism Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Metabolism Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Metabolism Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Metabolism Drugs Sales Value, 2019-2030

5.7.2 South America Metabolism Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Metabolism Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Metabolism Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Metabolism Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Metabolism Drugs Sales Value

6.2.1 Key Countries/Regions Metabolism Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Metabolism Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Metabolism Drugs Sales Value, 2019-2030

6.3.2 United States Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Metabolism Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Metabolism Drugs Sales Value, 2019-2030

6.4.2 Europe Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Metabolism Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Metabolism Drugs Sales Value, 2019-2030

6.5.2 China Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Metabolism Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Metabolism Drugs Sales Value, 2019-2030

6.6.2 Japan Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Metabolism Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Metabolism Drugs Sales Value, 2019-2030

6.7.2 South Korea Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Metabolism Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Metabolism Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Metabolism Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Metabolism Drugs Sales Value, 2019-2030

6.9.2 India Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Metabolism Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Metabolism Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Metabolism Drugs Product Offerings

7.1.5 Merck Recent Development

7.2 Novartis

7.2.1 Novartis Company Information

7.2.2 Novartis Introduction and Business Overview

7.2.3 Novartis Metabolism Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Novartis Metabolism Drugs Product Offerings

7.2.5 Novartis Recent Development

7.3 Takeda Pharmaceutical

7.3.1 Takeda Pharmaceutical Company Information

7.3.2 Takeda Pharmaceutical Introduction and Business Overview

7.3.3 Takeda Pharmaceutical Metabolism Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Takeda Pharmaceutical Metabolism Drugs Product Offerings

7.3.5 Takeda Pharmaceutical Recent Development

7.4 Astra Zeneca

7.4.1 Astra Zeneca Company Information

7.4.2 Astra Zeneca Introduction and Business Overview

7.4.3 Astra Zeneca Metabolism Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Astra Zeneca Metabolism Drugs Product Offerings

7.4.5 Astra Zeneca Recent Development

7.5 Beohrigher Ingelheim

7.5.1 Beohrigher Ingelheim Company Information

7.5.2 Beohrigher Ingelheim Introduction and Business Overview

7.5.3 Beohrigher Ingelheim Metabolism Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Beohrigher Ingelheim Metabolism Drugs Product Offerings

7.5.5 Beohrigher Ingelheim Recent Development

7.6 KOWA

7.6.1 KOWA Company Information

7.6.2 KOWA Introduction and Business Overview

7.6.3 KOWA Metabolism Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 KOWA Metabolism Drugs Product Offerings

7.6.5 KOWA Recent Development

7.7 Kythera

7.7.1 Kythera Company Information

7.7.2 Kythera Introduction and Business Overview

7.7.3 Kythera Metabolism Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Kythera Metabolism Drugs Product Offerings

7.7.5 Kythera Recent Development

7.8 Fuji yakuhin

7.8.1 Fuji yakuhin Company Information

7.8.2 Fuji yakuhin Introduction and Business Overview

7.8.3 Fuji yakuhin Metabolism Drugs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Fuji yakuhin Metabolism Drugs Product Offerings

7.8.5 Fuji yakuhin Recent Development

7.9 LG Life Science

7.9.1 LG Life Science Company Information

7.9.2 LG Life Science Introduction and Business Overview

7.9.3 LG Life Science Metabolism Drugs Sales, Revenue and Gross Margin (2019-2024)

7.9.4 LG Life Science Metabolism Drugs Product Offerings

7.9.5 LG Life Science Recent Development

7.10 Metsubishi Tanabe Pharma

7.10.1 Metsubishi Tanabe Pharma Company Information

7.10.2 Metsubishi Tanabe Pharma Introduction and Business Overview

7.10.3 Metsubishi Tanabe Pharma Metabolism Drugs Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Metsubishi Tanabe Pharma Metabolism Drugs Product Offerings

7.10.5 Metsubishi Tanabe Pharma Recent Development

8 Industry Chain Analysis

8.1 Metabolism Drugs Industrial Chain

8.2 Metabolism Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Metabolism Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Metabolism Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceutical

Metsubishi Tanabe Pharma

Novartis

Merck

List of Tables

Table 1. Metabolism Drugs Market Trends

Table 2. Metabolism Drugs Market Drivers & Opportunity

Table 3. Metabolism Drugs Market Challenges

Table 4. Metabolism Drugs Market Restraints

Table 5. Global Metabolism Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Metabolism Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Metabolism Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Metabolism Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Metabolism Drugs Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Metabolism Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Metabolism Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Metabolism Drugs

Table 13. Global Metabolism Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolism Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Metabolism Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Metabolism Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Metabolism Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Metabolism Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Metabolism Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Metabolism Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Metabolism Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Metabolism Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Metabolism Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Metabolism Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Metabolism Drugs Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Metabolism Drugs Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Metabolism Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Metabolism Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Metabolism Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Metabolism Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Metabolism Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Metabolism Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Metabolism Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Metabolism Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Metabolism Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Metabolism Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Metabolism Drugs Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Metabolism Drugs Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Metabolism Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Metabolism Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Metabolism Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Metabolism Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Metabolism Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Metabolism Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Metabolism Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Metabolism Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Metabolism Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Metabolism Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Metabolism Drugs Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Metabolism Drugs Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Metabolism Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Metabolism Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Metabolism Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Metabolism Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Metabolism Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Merck Metabolism Drugs Product Offerings

Table 61. Merck Recent Development

Table 62. Novartis Company Information

Table 63. Novartis Introduction and Business Overview

Table 64. Novartis Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Novartis Metabolism Drugs Product Offerings

Table 66. Novartis Recent Development

Table 67. Takeda Pharmaceutical Company Information

Table 68. Takeda Pharmaceutical Introduction and Business Overview

Table 69. Takeda Pharmaceutical Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Takeda Pharmaceutical Metabolism Drugs Product Offerings

Table 71. Takeda Pharmaceutical Recent Development

Table 72. Astra Zeneca Company Information

Table 73. Astra Zeneca Introduction and Business Overview

Table 74. Astra Zeneca Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Astra Zeneca Metabolism Drugs Product Offerings

Table 76. Astra Zeneca Recent Development

Table 77. Beohrigher Ingelheim Company Information

Table 78. Beohrigher Ingelheim Introduction and Business Overview

Table 79. Beohrigher Ingelheim Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Beohrigher Ingelheim Metabolism Drugs Product Offerings

Table 81. Beohrigher Ingelheim Recent Development

Table 82. KOWA Company Information

Table 83. KOWA Introduction and Business Overview

Table 84. KOWA Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. KOWA Metabolism Drugs Product Offerings

Table 86. KOWA Recent Development

Table 87. Kythera Company Information

Table 88. Kythera Introduction and Business Overview

Table 89. Kythera Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Kythera Metabolism Drugs Product Offerings

Table 91. Kythera Recent Development

Table 92. Fuji yakuhin Company Information

Table 93. Fuji yakuhin Introduction and Business Overview

Table 94. Fuji yakuhin Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Fuji yakuhin Metabolism Drugs Product Offerings

Table 96. Fuji yakuhin Recent Development

Table 97. LG Life Science Company Information

Table 98. LG Life Science Introduction and Business Overview

Table 99. LG Life Science Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. LG Life Science Metabolism Drugs Product Offerings

Table 101. LG Life Science Recent Development

Table 102. Metsubishi Tanabe Pharma Company Information

Table 103. Metsubishi Tanabe Pharma Introduction and Business Overview

Table 104. Metsubishi Tanabe Pharma Metabolism Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Metsubishi Tanabe Pharma Metabolism Drugs Product Offerings

Table 106. Metsubishi Tanabe Pharma Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Metabolism Drugs Downstream Customers

Table 110. Metabolism Drugs Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Metabolism Drugs Product Picture

Figure 2. Global Metabolism Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Metabolism Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Metabolism Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Metabolism Drugs Sales Price (2019-2030) & (USD/Unit)

Figure 6. Metabolism Drugs Report Years Considered

Figure 7. Global Metabolism Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Metabolism Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Metabolism Drugs Revenue in 2023

Figure 10. Metabolism Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Glycogen Metabolism Disease Drug Picture

Figure 12. Lipid Metabolism Disease Drug Picture

Figure 13. Amino Acid Metabolism Drug Picture

Figure 14. Other Picture

Figure 15. Global Metabolism Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Metabolism Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Metabolism Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Metabolism Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Metabolism Drugs Price by Type (2019-2030) & (USD/Unit)

Figure 20. Product Picture of Hospital

Figure 21. Product Picture of Retail Pharmacy

Figure 22. Global Metabolism Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Metabolism Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Metabolism Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Metabolism Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Metabolism Drugs Price by Application (2019-2030) & (USD/Unit)

Figure 27. North America Metabolism Drugs Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Metabolism Drugs Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Metabolism Drugs Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Metabolism Drugs Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Metabolism Drugs Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Metabolism Drugs Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Metabolism Drugs Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Metabolism Drugs Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Metabolism Drugs Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Metabolism Drugs Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Metabolism Drugs Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Metabolism Drugs Sales Volume (%), (2019-2030)

Figure 39. United States Metabolism Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Metabolism Drugs Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Metabolism Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Metabolism Drugs Sales Value by Application (%), 2023 VS 2030

Figure 45. China Metabolism Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

Figure 47. China Metabolism Drugs Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Metabolism Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Metabolism Drugs Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Metabolism Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Metabolism Drugs Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Metabolism Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Metabolism Drugs Sales Value by Application (%), 2023 VS 2030

Figure 57. India Metabolism Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Metabolism Drugs Sales Value by Type (%), 2023 VS 2030

Figure 59. India Metabolism Drugs Sales Value by Application (%), 2023 VS 2030

Figure 60. Metabolism Drugs Industrial Chain

Figure 61. Metabolism Drugs Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions